JSPR logo

Jasper Therapeutics (JSPR)

Profile

Full Name

Jasper Therapeutics, Inc.

Ticker Symbol

JSPR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 10, 2020

Indexes

Not included

Website

http://jaspertx.com

Employees

64

Key Details

Price

$4.00(+2.14%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$4.89(-691.26% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.00
JSPR price is $4.00

30-Day Relative Volume

0.95
JSPR 30-day relative volume is 0.95

Price Performance

Price Today change

+2.14%
JSPR price is up +2.14% today

Price YTD change

-81.27%
JSPR price is down -81.27% since January 1st

Price 1-year change

-83.19%
JSPR price is down -83.19% year-on-year

Price 3-year change

-85.95%
JSPR price is down -85.95% over the past 3 years

Price Range

Price All-time high

$188.80
JSPR price is currently -97.88% below its historical high of $188.80

Price 3-year low

$3.13
JSPR price is currently +27.92% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$60.15M
JSPR market capitalization is $60.15 million

Market cap 3-year change

-42.31%
JSPR market capitalization is down -42.31% over the past 3 years

Market cap All-time high

$620.94M
JSPR market capitalization is currently -90.31% below its historical high of $620.94 million

Market cap sector rank

41.45%
JSPR market capitalization is higher than 41.45% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.42%
JSPR shares outstanding is down -0.42% year-on-year

Shares Outstanding 3-Year Change

+310.66%
JSPR shares outstanding is up +310.66% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.23
JSPR beta is 1.23

200-day SMA

$15.26
JSPR price is currently -73.77% below its 200-day simple moving average

50-day SMA

$5.17
JSPR price is currently -22.50% below its 50-day simple moving average

RSI

36.73
JSPR 14-day relative strength index is 36.73

Volume

0.95
JSPR 30-day relative volume is 0.95

ATR

$0.39
JSPR average true range is $0.39

10-day Historical Volatility

95.10%
JSPR 10-day historical volatility is 95.10%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
JSPR annual revenue value is unknown

Revenue Analysts estimate

$4.89M
JSPR annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
JSPR annual revenue 1-year change is unknown

Revenue Sector rank

-
JSPR annual revenue is unknown

EPS

EPS

-$4.89
JSPR annual earnings per share is -$4.89

EPS Analysts estimate

-$5.52
JSPR annual earnings per share is currently -11.41% lower than the consensus analysts' forecast

EPS 1-year change

-691.26%
JSPR annual earnings per share is down -691.26% year-on-year

EPS Sector rank

19.5%
JSPR annual earnings per share is higher than 19.5% of companies in Healthcare sector

Profit

Gross profit

-
JSPR annual gross profit value is unknown

Gross margin

-
JSPR annual gross profit margin value is unknown

Operating profit

-$76.24M
JSPR annual operating income is -$76.24 million

Operating margin

-
JSPR annual operating profit margin value is unknown

Net income

-$71.27M
JSPR annual net profit is -$71.27 million

Net margin

-
JSPR annual net profit margin value is unknown

Expenses

Total expenses

$76.24M
JSPR annual total expenses is $76.24 million

Operating expenses

$76.24M
JSPR annual total operating expenses is $76.24 million

Cost of goods sold

-
JSPR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$20.42M
JSPR annual SGA is $20.42 million

Depreciation and amortization

$1.37M
JSPR annual depreciation & amortization is $1.37 million

Interest expense

-
JSPR annual interest expense value is unknown

Income tax

-
JSPR annual income tax value is unknown

EBIT & EBITDA

EBIT

-$76.24M
JSPR annual earnings before interest & taxes is -$76.24 million

EBITDA

-$74.87M
JSPR annual EBITDA is -$74.87 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$79.90M
JSPR annual total assets is $79.90 million

Non current assets

$4.09M
JSPR annual long term assets is $4.09 million

Current assets

$75.81M
JSPR annual total current assets is $75.81 million

Cash and cash equivalents

$71.64M
JSPR annual cash & cash equivalents is $71.64 million

Accounts receivable

-
JSPR annual accounts receivable value is unknown

Inventory

-
JSPR annual inventory value is unknown

Liabilities

Total liabilities

$18.23M
JSPR annual total liabilities is $18.23 million

Long term liabilities

$2.99M
JSPR annual total long term liabilities is $2.99 million

Current liabilities

$15.24M
JSPR annual total current liabilities is $15.24 million

Accounts payable

$4.03M
JSPR annual accounts payable is $4.03 million

Debt

Total debt

$1.81M
JSPR annual total debt is $1.81 million

Total debt 1-year change

-34.92%
JSPR annual total debt is down -34.92% year-on-year

Long term debt

$724.00K
JSPR annual long term debt is $724.00 thousand

Short term debt

$1.09M
JSPR annual short term debt is $1.09 million

Equity & Capital

Shareholders equity

$61.67M
JSPR annual stockholders equity is $61.67 million

Book value

$61.67M
JSPR annual book value is $61.67 million

Retained earnings

-$240.87M
JSPR annual retained earnings is -$240.87 million

Working capital

$60.57M
JSPR annual working capital is $60.57 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$62.60M
JSPR annual cash flow from operations is -$62.60 million

Cash from operations 1-year change

-20.23%
JSPR annual cash flow from operations is down -20.23% year-on-year

Cash from investing

-$532.00K
JSPR annual cash flow from investing activities is -$532.00 thousand

Cash from investing 1-year change

-99.25%
JSPR annual cash flow from investing activities is down -99.25% year-on-year

Cash from financing

$47.88M
JSPR annual cash flow from financing activities is $47.88 million

Cash from financing 1-year change

-52.58%
JSPR annual cash flow from financing activities is down -52.58% year-on-year

CAPEX

CAPEX

-
JSPR annual capital expenditures value is unknown

CAPEX 1-year change

-
JSPR annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$63.15M
JSPR annual free cash flow is -$63.15 million

Free cash flow 1-year change

-20.67%
JSPR annual free cash flow is down -20.67% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
JSPR annual gross profit margin value is unknown

Operating margin

-
JSPR annual operating profit margin value is unknown

Net margin

-
JSPR annual net profit margin value is unknown

ROA & ROE

ROA

-89.20%
JSPR annual return on assets is -89.20%

ROE

-115.56%
JSPR annual return on equity is -115.56%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
JSPR price to earnings ratio value is unknown

PE ratio Sector rank

-
JSPR price to earnings ratio is unknown

PB Ratio

PB ratio

0.98
JSPR price to book ratio is 0.98

PB ratio Sector rank

44.07%
JSPR price to book ratio is higher than 44.07% of companies in Healthcare sector

PS Ratio

PS ratio

-
JSPR price to sales ratio value is unknown

PS ratio Sector rank

-
JSPR price to sales ratio is unknown

Enterprise value

Enterprise value

-$9.68M
JSPR enterprise value is -$9.68 million

Enterprise value Sector rank

4.95%
JSPR enterprise value is higher than 4.95% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.13
JSPR EV/EBITDA is 0.13

EV/EBITDA Sector rank

67.74%
JSPR EV/EBITDA is higher than 67.74% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.98
JSPR annual current ratio is 4.98

Quick ratio

-
JSPR annual quick ratio value is unknown

Leverage

Debt to equity

0.03
JSPR annual debt to equity ratio is 0.03

Interest coverage ratio

-
JSPR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
JSPR piotroski f-score value is unknown

Altman Z-Score

-
JSPR altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 11, 25 HC Wainwright & Co.
Buy
Feb 13, 25 UBS
Buy
Jan 10, 25 JMP Securities
Market Outperform
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 9, 25 RBC Capital
Outperform
Jan 6, 25 JMP Securities
Market Outperform
Dec 23, 24 RBC Capital
Outperform
Dec 6, 24 BMO Capital
Outperform
Oct 24, 24 HC Wainwright & Co.
Buy
Oct 15, 24 JMP Securities
Market Outperform

Institutional Ownership

Similar stocks

IOBT logo
IO Biotech (IOBT)
ABOS logo
Acumen Pharmaceuticals (ABOS)
CCLD logo
CareCloud (CCLD)
ASRT logo
Assertio Holdings (ASRT)
BMEA logo
Biomea Fusion (BMEA)
VTGN logo
VistaGen Therapeutics (VTGN)
Acrivon Therapeutics (ACRV)
PYXS logo
Pyxis Oncology (PYXS)
Renovaro Biosciences (RENB)
  • What is the ticker symbol for Jasper Therapeutics?
  • Does Jasper Therapeutics pay dividends?
  • What sector is Jasper Therapeutics in?
  • What industry is Jasper Therapeutics in?
  • What country is Jasper Therapeutics based in?
  • When did Jasper Therapeutics go public?
  • Is Jasper Therapeutics in the S&P 500?
  • Is Jasper Therapeutics in the NASDAQ 100?
  • Is Jasper Therapeutics in the Dow Jones?
  • When was Jasper Therapeutics's last earnings report?
  • When does Jasper Therapeutics report earnings?
  • Should I buy Jasper Therapeutics stock now?

What is the ticker symbol for Jasper Therapeutics?

The ticker symbol for Jasper Therapeutics is NASDAQ:JSPR

Does Jasper Therapeutics pay dividends?

No, Jasper Therapeutics does not pay dividends

What sector is Jasper Therapeutics in?

Jasper Therapeutics is in the Healthcare sector

What industry is Jasper Therapeutics in?

Jasper Therapeutics is in the Biotechnology industry

What country is Jasper Therapeutics based in?

Jasper Therapeutics is headquartered in United States

When did Jasper Therapeutics go public?

Jasper Therapeutics's initial public offering (IPO) was on January 10, 2020

Is Jasper Therapeutics in the S&P 500?

No, Jasper Therapeutics is not included in the S&P 500 index

Is Jasper Therapeutics in the NASDAQ 100?

No, Jasper Therapeutics is not included in the NASDAQ 100 index

Is Jasper Therapeutics in the Dow Jones?

No, Jasper Therapeutics is not included in the Dow Jones index

When was Jasper Therapeutics's last earnings report?

Jasper Therapeutics's most recent earnings report was on Feb 27, 2025

When does Jasper Therapeutics report earnings?

The next expected earnings date for Jasper Therapeutics is May 14, 2025

Should I buy Jasper Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page